Follow your laboratory's SOPs
What we are developing could be used as something like maintenance therapy where you could get subcutaneous injections every 3 to 6 months. The market opportunity also resulted in a dramatic legal battle between Pfizer and Novo Nordisk last year, when the two companies fought over buying Metsera, a start-up developing weight-loss drugs
It is common for two or more appointments to be needed, most frequently exceeding 6-10
Shots are super easy to do
Moreover, when compared to astrocytes, oligodendrocytes possess less than half of the glutathione content, which leads to less effective peroxide scavenging due to the lower activity of glutathione peroxidase (Juurlink et al., 1998)
The FDA placed BPC-157 on its Category 2 list of bulk drug substances in late 2023, specifically citing safety unknowns